FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380995387> ?p ?o ?g. }

• W4380995387 endingPage "4533" @default.
• W4380995387 startingPage "4525" @default.
• W4380995387 abstract "Development of a universal influenza vaccine that can provide robust and long-lasting protection against heterologous infections is a global public health priority. A variety of vaccine antigens are designed to increase the antigenicity of conserved epitopes to elicit cross-protective antibodies that often lack virus-neutralizing activity. Given the contribution of antibody effector functions to cross-protection, adjuvants need to be added to modulate antibody effector functions as well as to enhance antibody quantity. We previously showed that post-fusion influenza vaccine antigens elicit non-neutralizing but cross-protective antibodies against conserved epitopes. Here, using a murine model, we comparably assessed the adjuvanticity of the newly developed SA-2 adjuvant containing a synthetic TLR7 agonist DSP-0546 and squalene-based MF59 analog as representative Th1- or Th2-type adjuvants, respectively. Both types of adjuvants in the post-fusion vaccine comparably enhanced cross-reactive IgG titers against heterologous strains. However, only SA-2 skewed the IgG subclass into the IgG2c subclass in association to its Th1-polarizing nature. SA-2-enhanced IgG2c responses exhibited antibody-dependent cellular cytotoxicity against heterologous virus strains, without cross-neutralizing activity. Eventually, the SA-2-adjuvanted vaccination provided protection against lethal infection by heterologous H3N2 and H1N1 viruses. Together, we conclude that the combination with a SA-2 is advantageous for enhancing the cross-protective capability of post-fusion HA vaccines that elicit non-neutralizing IgG antibodies." @default.
• W4380995387 created "2023-06-17" @default.
• W4380995387 creator A5011893599 @default.
• W4380995387 creator A5017315943 @default.
• W4380995387 creator A5041735439 @default.
• W4380995387 creator A5042644677 @default.
• W4380995387 creator A5043805550 @default.
• W4380995387 creator A5046016638 @default.
• W4380995387 creator A5046065065 @default.
• W4380995387 creator A5063977229 @default.
• W4380995387 creator A5064933484 @default.
• W4380995387 creator A5066612748 @default.
• W4380995387 creator A5087077261 @default.
• W4380995387 date "2023-07-01" @default.
• W4380995387 modified "2023-10-17" @default.
• W4380995387 title "Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses" @default.
• W4380995387 cites W1655706054 @default.
• W4380995387 cites W1907177142 @default.
• W4380995387 cites W1978755540 @default.
• W4380995387 cites W1979195886 @default.
• W4380995387 cites W1999495439 @default.
• W4380995387 cites W2002632348 @default.
• W4380995387 cites W2016329114 @default.
• W4380995387 cites W2024794372 @default.
• W4380995387 cites W2050257899 @default.
• W4380995387 cites W2063432056 @default.
• W4380995387 cites W2077219861 @default.
• W4380995387 cites W2083349939 @default.
• W4380995387 cites W2102099234 @default.
• W4380995387 cites W2106088492 @default.
• W4380995387 cites W2118362676 @default.
• W4380995387 cites W2119663701 @default.
• W4380995387 cites W2133282671 @default.
• W4380995387 cites W2138564764 @default.
• W4380995387 cites W2161738112 @default.
• W4380995387 cites W2163030812 @default.
• W4380995387 cites W2163135112 @default.
• W4380995387 cites W2223009545 @default.
• W4380995387 cites W2227857906 @default.
• W4380995387 cites W2342136111 @default.
• W4380995387 cites W2347085129 @default.
• W4380995387 cites W2417981936 @default.
• W4380995387 cites W2418848084 @default.
• W4380995387 cites W2491163602 @default.
• W4380995387 cites W2581994937 @default.
• W4380995387 cites W2588934593 @default.
• W4380995387 cites W2608948397 @default.
• W4380995387 cites W2790722089 @default.
• W4380995387 cites W2811457913 @default.
• W4380995387 cites W2901934218 @default.
• W4380995387 cites W2904196487 @default.
• W4380995387 cites W2945681432 @default.
• W4380995387 cites W2945953636 @default.
• W4380995387 cites W2955712962 @default.
• W4380995387 cites W2971256066 @default.
• W4380995387 cites W3005262031 @default.
• W4380995387 cites W3011964259 @default.
• W4380995387 cites W3033374666 @default.
• W4380995387 cites W3111038302 @default.
• W4380995387 cites W3173807830 @default.
• W4380995387 cites W4307863897 @default.
• W4380995387 doi "https://doi.org/10.1016/j.vaccine.2023.06.019" @default.
• W4380995387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37330368" @default.
• W4380995387 hasPublicationYear "2023" @default.
• W4380995387 type Work @default.
• W4380995387 citedByCount "1" @default.
• W4380995387 countsByYear W43809953872023 @default.
• W4380995387 crossrefType "journal-article" @default.
• W4380995387 hasAuthorship W4380995387A5011893599 @default.
• W4380995387 hasAuthorship W4380995387A5017315943 @default.
• W4380995387 hasAuthorship W4380995387A5041735439 @default.
• W4380995387 hasAuthorship W4380995387A5042644677 @default.
• W4380995387 hasAuthorship W4380995387A5043805550 @default.
• W4380995387 hasAuthorship W4380995387A5046016638 @default.
• W4380995387 hasAuthorship W4380995387A5046065065 @default.
• W4380995387 hasAuthorship W4380995387A5063977229 @default.
• W4380995387 hasAuthorship W4380995387A5064933484 @default.
• W4380995387 hasAuthorship W4380995387A5066612748 @default.
• W4380995387 hasAuthorship W4380995387A5087077261 @default.
• W4380995387 hasBestOaLocation W43809953871 @default.
• W4380995387 hasConcept C104317684 @default.
• W4380995387 hasConcept C147483822 @default.
• W4380995387 hasConcept C159047783 @default.
• W4380995387 hasConcept C159654299 @default.
• W4380995387 hasConcept C195616568 @default.
• W4380995387 hasConcept C203014093 @default.
• W4380995387 hasConcept C22070199 @default.
• W4380995387 hasConcept C2522874641 @default.
• W4380995387 hasConcept C2777546802 @default.
• W4380995387 hasConcept C2777863537 @default.
• W4380995387 hasConcept C2779026604 @default.
• W4380995387 hasConcept C2779261636 @default.
• W4380995387 hasConcept C2780115692 @default.
• W4380995387 hasConcept C55493867 @default.
• W4380995387 hasConcept C86803240 @default.
• W4380995387 hasConceptScore W4380995387C104317684 @default.
• W4380995387 hasConceptScore W4380995387C147483822 @default.
• W4380995387 hasConceptScore W4380995387C159047783 @default.

• next